CRDO Cash Flow Statement

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 2, 2026	May '25 May 3, 2025	Apr '24 Apr 27, 2024	Apr '23 Apr 29, 2023	Apr '22 Apr 30, 2022
Net Income	472.28	52.18	-28.37	-16.55	-22.18
Depreciation & Amortization	35.04	21.94	13.77	9.51	4.79
Stock-Based Compensation	182.64	77.36	39.02	23.52	9.19
Other Adjustments	16.62	22.01	9.04	9.32	6.97
Change in Receivables	-70.8	-102.48	-10.12	-20.02	-15.88
Changes in Inventories	-174.04	-70.47	15.76	-24.38	-21.68
Changes in Accounts Payable	48.75	41.93	8.81	-3.84	4.75
Changes in Accrued Expenses	25.06	15.93	5.31	3.68	9.6
Changes in Unearned Revenue	-	-	-	-	-2.88
Changes in Other Operating Activities	-71.25	6.69	-20.49	-5.86	-3.52
Operating Cash Flow	464.29	65.08	32.74	-24.62	-30.83
Operating Cash Flow Growth	613.38%	98.81%	-	-	-
Capital Expenditures	-57.3	-36.06	-15.65	-21.71	-17.58
Purchases of Investments	-393.33	-258.73	-403.59	-159.23	-
Proceeds from Sale of Investments	310.01	406.78	169.75	50	-
Payments for Business Acquisitions	-112.91	-	-	-	-
Investing Cash Flow	-253.53	111.99	-249.49	-130.94	-17.58
Issuance of Common Stock	743.41	7.83	180.49	5.5	196.94
Repurchase of Common Stock	-19.16	-9.25	-2.16	-	-
Net Common Stock Issued (Repurchased)	724.25	-1.42	178.33	5.5	196.94
Issuance of Preferred Stock	-	-	-	-	7.25
Net Preferred Stock Issued (Repurchased)	-	-	-	-	7.25
Other Financing Activities	-6.62	-6.31	-3.05	-0.62	-
Financing Cash Flow	717.63	-7.73	175.28	4.89	204.18
Effect of Exchange Rate Changes on Cash and Cash Equivalents	0.23	0.04	-0.17	-0.07	-0.2
Net Cash Flow	928.62	169.39	-41.64	-150.74	155.57
Free Cash Flow	407	29.02	17.09	-46.33	-48.41
Free Cash Flow Growth	1302.37%	69.87%	-	-	-
FCF Margin	30.48%	6.64%	8.85%	-25.15%	-45.47%
Free Cash Flow Per Share	2.16	0.16	0.11	-0.32	-0.55
Levered Free Cash Flow	278.54	32.14	-20.86	-59.15	-48.69
Unlevered Free Cash Flow	248.31	15.26	-38.71	-62.21	-48.45

SEC Filings: 10-K · 10-Q